Motif Bio

Corporate Controller

  • Transformed the finance and accounting organization to support the needs of a dynamic dual-listed public entity;

     - Collaborated with and directly supported the leadership team in evaluating multiple strategic opportunities related to 

     product pipeline expansion, commercial operations and licensing activities.

     - Supported multiple equity financings and negotiation of term loan to facilitate capital needs and minimize financial


Aerie Pharmaceuticals, Inc.
Director of Finance and Accounting

  • Directly supported Company’s transition from a privately to publicly held entity (IPO in October 2013), including strategic financial modeling.

     - Leadership role in establishing the Company’s alignment in its corporate structure with its international business

     strategy, including international feasibility assessment and establishing wholly-owned subsidiaries.

PricewaterhouseCoopers LLP
Manager Assurance Services

  • Managed audit engagements of privately held and public companies in various industries, supervised engagement teams (3-10+ people) and coordinated the efforts of international audit teams and cross-functional service team members. Participated in multiple special purpose opportunities, including IPO  

College of New Jersey

  • Bachelor’s Degree, Accounting
  • 1996 to 1999

Ralph Annette: Finance –Forecasting, P&L Generation, Valuation, Licensing, M&A

Payer and Finance Team

Norm Smith: Payer/Reimbursement Strategy, Value Proposition, Pricing

BAL Pharma Consulting, Limited Liability Company

President and Founder of Viewpoint Consulting, Inc. (Sold to Research America in 2016)

  • Lead consulting services to pharmaceutical and biotech companies, focused particularly on product marketing to “concentrated buyers” within Managed Markets.  Areas of special interest and expertise were pricing, contracting, formulary access, determining payer value propositions, identifying and establishing relationships with evolving payer decision makers.



  • Adjunct Professor, Managed Care Marketing  1999 – Present
  • Conduct an ongoing course at St Joseph’s University Pharmaceutical MBA program, Marketing to Managed Care.


  • Director of Business Services of Johnson & Johnson Health Care Systems  1994 – 1995
  • Founding member and director of business services of Johnson & Johnson Health Care Systems, a group that represented the operating companies of J&J to managed care.  


  • Director of Managed Care Marketing  1991 – 1994
  • Joined Janssen Pharmaceuticals Inc. as director of managed care. In this role, I was part of the team responsible for the successful launches of Propulsid® and Risperdal®, and built a sales group of 18.


  • Director of Managed Care  1988 – 1991
  • Recruited by Genentech as their first director of managed care.  Responsible for negotiating contracts and service agreements with various hospital chains.


  • Member, Academy of Managed Care Pharmacy (AMCP) Editorial Board Member Board Member,    Managed Care Today


  • Bachelor of Arts, Montclair State University (Montclair, New Jersey)